Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

BECKMAN COULTER, INC.

Beckman Coulter develops, manufactures and markets laboratory systems, reagents, centrifugation, lab automation, elec... read more Featured Products: More products

Download Mobile App




ALT/AST Ratio Is an Independent Risk Factor for Gestational Diabetes Mellitus

By LabMedica International staff writers
Posted on 02 Feb 2022
Gestational diabetes mellitus (GDM) is defined as a state of impaired glucose tolerance first being discovered during pregnancy. More...
GDM increases the risk of pregnancy complications and adverse perinatal outcomes, such as pregnancy-induced hypertension, preeclampsia, abortion, premature delivery, premature ruptures of membranes, and large for gestational age infants.

GDM also increases the risk of type 2 diabetes (T2DM) for mother in the future and influences the metabolism of offspring in the long run, bringing both public health and economic burden. Aspartate aminotransferase-to-alanine transaminase ratio (AST/ALT) has been reported not only an assessment tool of hepatic diseases, but also a valuable prognostic tool for cardiovascular disease, arterial stiffness, cancers, and chronic kidney disease. Recently it has been of great interest as a possible novel marker for metabolic syndrome and insulin resistance.

Endocrinologists at the Peking Union Medical College Hospital (Beijing, People’s Republic of China) and their colleagues included in a prospective, double-center, observational cohort study, a total of 1,128 pregnant women. Blood samples were collected at the first prenatal visit and 75-gram oral glucose tolerance test (OGTT) was conducted for all participants during 24 to 28 weeks of gestation. Biochemical parameters presented in the present study, including ALT, AST, total bilirubin (TBil), total cholesterol (TC), triglycerides (TG), low and high density lipoprotein cholesterol (LDL-C, HDL-C), were measured by Beckman AU5800 automatic analyzer (Beckman Coulter, Brea, CA, USA). Quality controls were performed by Bio-Rad biochemical quality control product (Bio-Rad Laboratories, Hercules, CA, USA).

The investigators reported that the incidence of GDM was 22.07% (249/1,128). ALT/AST ratio was higher in GDM group than in NGT group (0.92 versus 0.80). ALT/AST had positive correlations with fasting blood glucose, 1-hour and 2-hour blood glucose concentration during OGTT (0.089, 0.176, and 0.115, respectively). The odds ratio (OR) of ALT/AST for incidence of GDM was 1.603. The ROC-AUC of ALT/AST and TG/HDL-C reached 0.615 and 0.619, respectively.

The authors concluded that higher ALT/AST in early pregnancy, even within the normal range, was an independent risk factor of GDM. ALT/AST presented similar predictive ability to TG/HDL-C for GDM in this cohort study. The study was published on January 5, 2022 in the International Journal of General Medicine.

Related Links:
Peking Union Medical College Hospital
Beckman Coulter
Bio-Rad Laboratories



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Immunofluorescence Analyzer
IFA System
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.